IMMUNE DYSFUNCTION + CLINICAL IMMUNOLOGY
YEAR 1 | PAGE 12B - HYPERSENSITIVITY, IMMUNODEFICIENCY, AUTOIMMUNITY & TRANSPLANT
Use mechanism to classify disease: TOO MUCH/WRONG TARGET -> hypersensitivity/autoimmunity; TOO LITTLE -> immunodeficiency; FOREIGN TISSUE -> transplant rejection. Organize every syndrome by the immune arm involved, timing, laboratory pattern and expected infection/injury phenotype.
B. CLINICAL-IMMUNOLOGY VIDEOS - CORE + ENRICHMENT
| # | Video | Time | Why | Link |
|---|---|---|---|---|
| 1. | Type I Hypersensitivity - Osmosis from Elsevier | Type I | IgE sensitization, mast-cell activation, mediators, anaphylaxis and atopy - a concise visual bridge from mechanism to clinical pattern. | Open → |
| 2. | Type II Hypersensitivity - Osmosis from Elsevier | Type II | Antibody-mediated cell/tissue injury, complement and receptor effects; connect the mechanism to hemolysis, Goodpasture, Graves and myasthenia. | Open → |
| 3. | Hypersensitivity Type III - Armando Hasudungan | Type III | Immune-complex deposition, complement activation and inflammation with classic renal, pulmonary and systemic examples. | Open → |
| 4. | Approach to Primary Immunodeficiencies - Osmosis | clinical framework | Clinical decision-tree approach using age, infection pattern, syndromic clues and immune compartment to differentiate major disorders. | Open → |
| 5. | Immunodeficiencies: Combined T- and B-cell Disorders - Osmosis | ~19 min | SCID, DiGeorge, Wiskott-Aldrich, ataxia-telangiectasia and other combined defects organized by mechanism and phenotype. | Open → |
| 6. | Type IV / Delayed Hypersensitivity Clinical Enrichment - Armando Hasudungan | ENRICHMENT | T-cell-mediated delayed hypersensitivity applied to drug reactions and inflammatory tissue injury; useful to complete the I-IV framework. | Open → |
B. CLINICAL-IMMUNOLOGY VIDEOS - CORE + ENRICHMENT — CLINICAL IMMUNOLOGY CHECK
- Classify Types I-IV by effector, timing, tissue-injury mechanism and classic disease examples.
- For each primary immunodeficiency: immune defect -> infection pattern -> age/presentation -> key lab -> prevention/treatment principle.
- Distinguish autoantibody-mediated receptor disease from immune-complex disease and from T-cell-mediated tissue injury.
- Differentiate hyperacute, acute cellular/antibody-mediated and chronic transplant rejection; separate graft rejection from GVHD. VIDEO-FIRST | SCHOOL-EXAM + BOARD-EXAM MASTERY